New Novartis treatment shifts diabetes strategy
A new drug developed by Novartis AG for patients with type 2 diabetes helps control mealtime blood-glucose levels and could lead to a shift in strategies for treating the illness.The drug Starlix was
A new drug developed by Novartis AG for patients with type 2 diabetes helps control mealtime blood-glucose levels and could lead to a shift in strategies for treating the illness.The drug Starlix was